Medtronic (BSP:MDTC34) Payments of Debt: R$-23,325 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:MDTC34 Medtronic PLC BSP:MDTC34
72 GF Score
Price R$213.40
GF Value R$247.55
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Payments of Debt?

Medtronic BSP:MDTC34 +0.31% 72 Payments of Debt is R$-23,325 Mil as of Apr. 2026. GuruFocus rates BSP:MDTC34 with a GF Score™ of 72/100 and a GF Value™ of R$247.55 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Medtronic's Payments of Debt for the three months ended in Apr. 2026 was R$-826 Mil.

Medtronic's Payments of Debt for the trailing twelve months (TTM) ended in Apr. 2026 was R$-23,325 Mil.

Medtronic Payments of Debt Related Terms

Medtronic Payments of Debt Historical Data

* Premium members only.

The historical data trend for Medtronic's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Payments of Debt Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.76 -41,633.26 0.00 -6,195.84 -14,749.33

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -6,429.58 -9,517.50 -6,552.54 -825.56
BSP:MDTC34
72GF Score
Medtronic PLC BSP:MDTC34
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-23,325 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of R$-23,325 Mil mean?
Medtronic (BSP:MDTC34) has a Payments of Debt of R$-23,325 Mil as of Apr. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Medtronic and its competitors.
Is Medtronic's Payments of Debt too high?
Medtronic's current Payments of Debt is R$-23,325 Mil. Overall, Medtronic has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Payments of Debt compare to SYK and BSX?
Medtronic's Payments of Debt of R$-23,325 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Medical Devices & Instruments company?
A good Payments of Debt depends on the Medical Devices & Instruments industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Medtronic and its competitors. Medtronic's current Payments of Debt is R$-23,325 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BSP:MDTC34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$247.55, compared to a current price of R$213.40 — trading 13.8% below its estimated fair value. The current Payments of Debt is R$-23,325 Mil. Medtronic's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Medtronic (BSP:MDTC34), the current Payments of Debt is R$-23,325 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BSP:MDTC34) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of R$213.40 is trading 13.8% below its estimated GF Value™ of R$247.55. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BSP:MDTC34:

  • Payments of Debt: R$-23,325 Mil
  • GF Value™: R$247.55 vs. price of R$213.40 (13.8% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the BSP:MDTC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
72GF Score

Get the complete analysis for BSP:MDTC34

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$213.40
Price
R$247.55
GF Value